BERLIN , Feb. 29, 2024 /PRNewswire/ -- Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, is pleased to announce that it has ...
New collaboration helps address barriers to clinical trials participation, expands resources to patients and caregivers CHESTER, N.J. , Feb. 28, 2024 /PRNewswire-PRWeb/ -- Cancer Hope Network and Lazarex Cancer Foundation announced ...
Using RNA sequencing and spatial transcriptomics, the roles of PKM gene and EPHA2 pathway in the development of HNSCC were discovered. BUSAN, South Korea , Feb. 28, 2024 /PRNewswire/ -- Head and neck squamous cell carcinoma (HNSCC) is ...
HONG KONG , Feb. 28, 2024 /PRNewswire/ -- Akeso (9926.HK) announced that the results of a phase II clinical trial for PD-1/CTLA-4 bispecific antibody(cadonilimab)combined with standard treatment (chemotherapy +/- bevacizumab) as ...
LONDON , Feb. 27, 2024 /PRNewswire/ -- C the Signs , a British AI technology company founded by NHS Doctors at the forefront of early cancer detection, has been announced as part of the inaugural cohort of the White House CancerX ...
SYDNEY , Feb. 26, 2024 /PRNewswire/ -- In an unprecedented feat of endurance and dedication to cancer research, Lance Kawaguchi , Chief Executive Officer of Cure Brain Cancer Foundation, successfully completed a challenging trek at the ...
PLEASANTON, Calif. , Feb. 26, 2024 /PRNewswire/ -- DiaCarta, Inc. ("DiaCarta"), a pioneer in molecular diagnostic test development for cancer and infectious diseases, today announced that it has established a strategic collaboration with ...
- The first EpCAM targeted CAR-T product obtained US/CN IND approval. - Acceptable safety profiles and preliminary efficacy were observed in Investigator-Initiated Trial ( IIT ) clinical studies of IMC001. SHANGHAI , Feb. ...
Data demonstrates pharmacological inhibition of METTL1 inhibits tumour growth and reduces tRNA methylation and stability of tRNAs CAMBRIDGE, England , Feb. 22, 2024 /PRNewswire/ -- STORM Therapeutics Ltd. (STORM), the clinical ...
Kling reports on advancing pipeline of therapeutic antibodies targeting novel antigens discovered with its best-in-class B-cell screening platform, Kling-Select Progress on in vitro and in vivo validation of two highly specific tumor ...
A recent study conducted by the Keck School of Medicine of USC has uncovered a significant genetic variant located on the IKZF1 gene, shedding light on the heightened risk of Acute Lymphoblastic Leukemia (ALL) ( ). Through genetic fine-mapping ...
In India, there is a notable increase in colon or colorectal cancer cases among young adults. This surge is attributed to delayed diagnoses, inadequate screening, and the adoption of a Western diet characterized by highly processed and calorie-rich ...
Scientists at Fred Hutchinson Cancer Research Center have discovered that a particular subtype of microbe Fusobacterium nucleatum, often present in oral microbiota, can migrate to the gut and thrive within colorectal cancer tumors. This microbe has ...
Pharmaceutical giant Dr. Reddy’s Laboratories Ltd (DRL) unveiled the release of its cancer medication Versavo (bevacizumab) in the United Kingdom ( ). Dr. Reddy’s Launches Versavo, First Biosimilar in UK for Treating Various Cancers ...
Although the recommended age for receiving the HPV vaccine is between 9 and 14, women who missed the vaccination during this period can still gain partial protection against...
Subscribe to our Free Newsletters!